{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:35:29Z","timestamp":1774647329223,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ijcard.2016.09.044","type":"journal-article","created":{"date-parts":[[2016,9,17]],"date-time":"2016-09-17T16:45:23Z","timestamp":1474130723000},"page":"252-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation"],"prefix":"10.1016","volume":"224","author":[{"given":"Wanwarang","family":"Wongcharoen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adisai","family":"Ruttanaphol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siriluck","family":"Gunaparn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arintaya","family":"Phrommintikul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.09.044_bb0005","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jacc.2003.11.032","article-title":"The atrial fibrillation follow-up investigation of rhythm management (affirm) study: approaches to control rate in atrial fibrillation","volume":"43","author":"Olshansky","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0010","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0020","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0735-1097(98)00561-0","article-title":"Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens","volume":"33","author":"Farshi","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.CIR.83.1.52","article-title":"Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group","volume":"83","author":"Goldstein","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.09.044_bb0035","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCRESAHA.109.208041","article-title":"The role of the funny current in pacemaker activity","volume":"106","author":"DiFrancesco","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0040","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (shift): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.09.044_bb0045","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.RES.0000101913.95604.B9","article-title":"Site of origin and molecular substrate of atrioventricular junctional rhythm in the rabbit heart","volume":"93","author":"Dobrzynski","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0050","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.yjmcc.2010.12.017","article-title":"Molecular architecture of the human specialised atrioventricular conduction axis","volume":"50","author":"Greener","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0055","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.yjmcc.2011.09.005","article-title":"Novel insights into the distribution of cardiac HCN channels: an expression study in the mouse heart","volume":"51","author":"Herrmann","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0060","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00005344-199810000-00002","article-title":"A double-blind placebo-controlled evaluation of the human electrophysiologic effects of zatebradine, a sinus node inhibitor","volume":"32","author":"Chiamvimonvat","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0065","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/00005344-199512000-00016","article-title":"Inhibition of the subsidiary pacemaker activity by zatebradine, an if inhibitor, in the anesthetized dog heart","volume":"26","author":"Yamazaki","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0070","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.hrthm.2013.08.007","article-title":"Inhibition of i(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation","volume":"10","author":"Verrier","year":"2013","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0075","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.hrthm.2014.08.007","article-title":"If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation","volume":"11","author":"Verrier","year":"2014","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0080","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1046\/j.1540-8167.2001.01404.x","article-title":"Electrical remodeling and atrial dilation during atrial tachycardia are influenced by ventricular rate: role of developing tachycardiomyopathy","volume":"12","author":"Schoonderwoerd","year":"2001","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0085","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/01.CIR.103.5.691","article-title":"Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation","volume":"103","author":"Schotten","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.09.044_bb0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijcard.2015.08.207","article-title":"Addition of ivabradine to betablockers in patients with atrial fibrillation: effects on heart rate and exercise tolerance","volume":"202","author":"Giuseppe","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijcard.2014.04.183","article-title":"Might ivabradine be useful in permanent atrial fibrillation?","volume":"175","author":"Moubarak","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2014.10.062","article-title":"Ivabradine for rate control in atrial fibrillation","volume":"179","author":"Kosiuk","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.09.044_bb0105","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/ejhf.258","article-title":"Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the shift holter substudy","volume":"17","author":"Bohm","year":"2015","journal-title":"Eur. J. Heart Fail."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316323002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316323002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T06:25:12Z","timestamp":1536387912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316323002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":21,"alternative-id":["S0167527316323002"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.09.044","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.09.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}